Webcasts


January 19, 2015


Plenary Session
Greetings, Y. Rozenman, President, Israel Heart Society


P. Asfar, France


Sponsored by Lilly lilly - logo
The immediate effect of new antiplatelet agents in patients with ACS: Should we preload the patient?
E. Lev, Israel


The contemporary use of new antiplatelet agents: Barriers and clinical benefits
S. Matetzky, Israel


January 20, 2015


Plenary Session
How solid are the guidelines? A critical review of the ACS guidelines
S. Kaul, USA


Case presentation
A. Shimony, Israel


Sponsored by AstraZeneca AstraZeneca logo
Y. Rozenman, Israel


Y. Rozenman, Israel


New and upcoming data regarding Ticagrelor in ACS and PCI
G. Steg, France


Sponsored by Boehringer Ingelheim Boehringer Ingelheim logo
Dabigatran as part of “Triple” therapy in patients suffering from acute coronary syndrome and atrial fibrillation – conclusions from clinical trial and real-world data
A. Pollak, Israel


Sponsored by Pfizer Pfizer Logo small
Comparison of Apixaban, Dabigatran and Rivaroxaban in the acute treatment and prevention of venous thromboembolism
S. Berliner, Israel